Pancreatic Cancer Research

ResearcherNational Institutes of HealthActive in the last 2 years

Nicholas D. Klemen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1353-539X; OpenAlex author ID A5031065511. Sources: ClinicalTrials.gov.

Their work

Papers
1
Trials
1 (principal investigator on 1)
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2025: 1 paper, 1 trial

Papers 1

  1. A platform for multisite immune profiling of premetastatic pancreatic cancer at single-cell resolution. Co-author DOI 10.1007/s00262-025-04146-5↗

Trials 1

  1. A Phase II Study of Adjuvant Immunotherapy Targeting KRAS G12D, KRAS G12V, or TP53 R175H for Participants With Advanced Gastrointestinal Malignancies Principal investigator NCT06690281↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Julia Button · 1 shared paper, 2025 · strength 0.20
  2. Tao Wang · 1 shared paper, 2025 · strength 0.20
  3. Erika J. Crosby · 1 shared paper, 2025 · strength 0.20
  4. Austin M. Eckhoff · 1 shared paper, 2025 · strength 0.20
  5. Dan German Blazer · 1 shared paper, 2025 · strength 0.20
  6. Michael E. Lidsky · 1 shared paper, 2025 · strength 0.20
  7. Sabino Zani · 1 shared paper, 2025 · strength 0.20
  8. Elishama N. Kanu · 1 shared paper, 2025 · strength 0.20
  9. Ethan S. Agritelley · 1 shared paper, 2025 · strength 0.20
  10. Peter J. Allen · 1 shared paper, 2025 · strength 0.20
  11. Daniel P. Nussbaum · 1 shared paper, 2025 · strength 0.20

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.